DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

82.35 -0.84 (-1.01%)

REAL-TIME: Last trade at

Extended Hours: $82.35 $0.00 (0.00%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

LLY $82.35 -1.01%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $83.41
Previous Close $83.19
Daily Range $82.05 - $84.42
52-Week Range $60.58 - $90.18
Market Cap $91.3B
P/E Ratio 43.10
Dividend (Yield) $2.00 (2.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,441,160
Average Daily Volume 4,845,191
Current FY EPS $3.27




Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website:

News & Commentary Rss Feed

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

Bristol-Myers Inks Another Immuno-Oncology Drug Deal

Why Eli Lilly (LLY) Could Beat Earnings Estimates Again

Approval Of Repatha May Give Amgen A $5B Boost.

Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval

Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock?

Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled

Novo Nordisk to Start PIONEER Program on Semaglutide

Benzinga's Top Initiations

Eli Lilly's Diabetes Drug May Halt Heart Disease

Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.

See More LLY News...

LLY's Top Competitors

LLY $82.35 (-1.01%)
Current stock: LLY
JNJ $93.98 (-1.25%)
Current stock: JNJ
NVS $97.22 (-1.15%)
Current stock: NVS
RHHBY $34.16 (-0.01%)
Current stock: RHHBY